{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:29:13Z","timestamp":1794216553847,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jneuroim.2026.579082","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:11:34Z","timestamp":1788451894000},"page":"579082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The pooled prevalence of cognitive impairment in adults with myelin oligodendrocyte glycoprotein antibody-associated disease: A Systematic Review &amp; Meta-Analysis"],"prefix":"10.1016","volume":"421","author":[{"given":"Albert","family":"Aboseif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlo","family":"Toljan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Niederschweiberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Gerberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579082_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2018.10.016","article-title":"Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein","volume":"130","author":"Akaishi","year":"2019","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579082_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579082_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-12-55","article-title":"Brief international cognitive assessment for MS (BICAMS): international standards for validation","volume":"12","author":"Benedict","year":"2012","journal-title":"BMC Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579082_bb0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579082_bb0030","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume":"4(1002)","author":"Chandler","year":"2019"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579082_bb0035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579082_bb0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ana.24769","article-title":"Preclinical disease activity in multiple sclerosis: a prospective study of cognitive performance prior to first symptom","volume":"80","author":"Cortese","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579082_bb0045","author":"Covidence systematic review software"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579082_bb0050","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00415-018-8835-6","article-title":"Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study","volume":"265","author":"de Mol","year":"2018","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jneuroim.2026.579082_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103689","article-title":"Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"59","author":"Fabri","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70310","article-title":"Cognitive outcomes in myelin oligodendrocyte glycoprotein-IgG associated disease compared to multiple sclerosis","volume":"15","author":"Galvani","year":"2025","journal-title":"Brain Behav."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579082_bb0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/00207454.2021.1954642","article-title":"Understanding visual-spatial perceptual deficits in individuals with multiple sclerosis: an analysis of patient performance on the Hooper visual organization test and visual form discrimination","volume":"133","author":"Gontkovsky","year":"2023","journal-title":"Int. J. Neurosci."},{"issue":"4\u20135","key":"10.1016\/j.jneuroim.2026.579082_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/13524585221127941","article-title":"A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The international classification of cognitive disorders in MS (IC-CoDiMS)","volume":"29","author":"Hancock","year":"2023","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579082_bb0080","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1177\/13524585231187283","article-title":"Predicting employment deterioration with the processing speed test (PST) and SDMT in multiple sclerosis","volume":"29","author":"Jaworski","year":"2023","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579082_bb0085","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200325","article-title":"Cognitive impairment, associated clinical factors, and MR volumetric measures in myelin oligodendrocyte glycoprotein-IgG-associated disease","volume":"11","author":"Kogel","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0090","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/acn3.51976","article-title":"Domain-specific cognitive impairment in multiple sclerosis: a systematic review and meta-analysis","volume":"11","author":"Lugosi","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70115","article-title":"Cognitive profile in adult patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a comparative study with multiple sclerosis","volume":"32","author":"Maniscalco","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ana.26301","article-title":"Reduction in cognitive processing speed surrounding multiple sclerosis relapse","volume":"91","author":"McKay","year":"2022","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579082_bb0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/1352458515599075","article-title":"Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression","volume":"22","author":"Moccia","year":"2016","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579082_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid. Based Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/jnnp-2024-333994","article-title":"Neuromyelitis Optica study group (NEMOS). Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-study)","volume":"96","author":"Passoke","year":"2026","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.579082_bb0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jclinepi.2019.11.019","article-title":"Grading of recommendations assessment, development, and evaluations (GRADE) notes: extremely serious, GRADE\u2019s terminology for rating down by three levels","volume":"120","author":"Piggott","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jneuroim.2026.579082_bb0125","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2025"},{"key":"10.1016\/j.jneuroim.2026.579082_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123413","article-title":"Longitudinal assessment of cognitive function in patients with non-relapsing MOG-IgG associated disease","volume":"470","author":"Risi","year":"2025","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579082_bb0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","article-title":"Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis","volume":"14","author":"Rocca","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579082_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13582-3","article-title":"Cognitive function in patients with myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"273","author":"Rust","year":"2026","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579082_bb0145","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s11136-025-03928-9","article-title":"Effect of impairment on health-related quality of life in people with multiple sclerosis: association of functional systems and EQ-5D-5L index values in a cross-sectional study","volume":"34","author":"Schmidt","year":"2025","journal-title":"Qual. Life Res."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579082_bb0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","article-title":"Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing","volume":"78","author":"Sechi","year":"2021","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579082_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/135245850100700608","article-title":"Visuoperceptual impairment in MS patients: nature and possible neural origins","volume":"7","author":"Vleugels","year":"2001","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579082_bb0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11065-024-09640-8","article-title":"The prevalence of cognitive impairment in relapsing-remitting multiple sclerosis: a systematic review and Meta-analysis","volume":"35","author":"Wu","year":"2025","journal-title":"Neuropsychol. Rev."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:19:15Z","timestamp":1794215955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S0165572826002316"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579082","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pooled prevalence of cognitive impairment in adults with myelin oligodendrocyte glycoprotein antibody-associated disease: A Systematic Review & Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579082"}}